Amphipathic Motifs, Lipoproteins and Atherosclerosis
Project Number5P01HL034343-18
Former Number2P01HL034343-07
Contact PI/Project LeaderSEGREST, JERE P
Awardee OrganizationUNIVERSITY OF ALABAMA AT BIRMINGHAM
Description
Abstract Text
DESCRIPTION (provided by applicant):
The central theme of this competitive renewal application for our PPG is based upon three
hypotheses: (1) apolipoprotein (apo) A-I-containing lipoproteins play a major role in
atherogenesis; (2) apoB-containing lipoproteins play a major role in atherogenesis; and (3) the
properties of the different apolipoprotein domains involved in the regulation of the functions of
the apoA-I- and apoB-containing lipoproteins are determined to a major extent by the
properties of the amphipathic motifs ubiquitous to apolipoproteins. From this we derive our
central theme: amphipathic motifs (the amphipathic alpha helix and the amphipathic beta
strand/sheet) are fundamental to a full understanding of the cause and reversal of
atherosclerosis. Amphipathic motifs represent the fundamental paradigm guiding all proposed
projects. The objectives in the next five years are to continue development of a comprehensive
theory of the interaction of amphipathic motifs with lipid and to use this knowledge to: (a)
determine the minimal structural features of apoA-I and apoE that can prevent and/or reverse
atherosclerosis, (b) determine the minimal structural features of apoB that are involved in both
the biosynthesis of apoB-containing lipoproteins and the structure, function and properties of
LDL, and (c) apply this knowledge to understand mechanisms involved in prevention and
reversal of atherosclerosis and potentially for the development of pharmacological agents. To
accomplish these objectives, four projects are proposed: 1) Structure-function of apoA-Icontaining lipoproteins (Dr. Jere P. Segrest, Project Leader). 2) Structure and assembly of apoBcontaining lipoproteins (Dr. Nassrin Dashti, Project Leader). 3) Antiatherogenic amphipathic
peptides: Structure-function (Dr. G. M. Anantharamiah, Project Leader). 4) Apolipoproteins and
functional mimics: in vivo studies (Dr. David W. Garber, Project Leader). To support these
projects, three core facilities are proposed: Core A: Administration, Computer and
Instrumentation (Dr. Segrest), Core B: Peptide Synthesis and Protein Purification (Dr.
Anantharamaiah), and Core C: Molecular Biology (Dr. Ling Li).
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
amphiphilicityapolipoproteinsatherosclerosisblood lipoproteinclinical researchprotein structure function
No Sub Projects information available for 5P01HL034343-18
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01HL034343-18
Patents
No Patents information available for 5P01HL034343-18
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01HL034343-18
Clinical Studies
No Clinical Studies information available for 5P01HL034343-18
News and More
Related News Releases
No news release information available for 5P01HL034343-18
History
No Historical information available for 5P01HL034343-18
Similar Projects
No Similar Projects information available for 5P01HL034343-18